We're inviting you to take part in a study for a new investigational COVID-19 vaccine. No health insurance is required to participate. You will receive all study related care and the vaccine at no cost to you. In addition, compensation for study-related travel may be provided.
What happens if I sign up?
We will match you to a clinical study location in your area that needs participants for a COVID-19 Vaccine Study or notify you when one becomes available. The study team will then contact you and you may have the opportunity to participate if you qualify.
If you think you might like to participate in the COVID-19 Vaccine Study or would like more information, please enter your information below so we can see if you may qualify and can contact you about the study. Keep in mind that participation is entirely voluntary. If you do decide to take part in a study, you may change your mind about participating at any time.
In late 2019, a novel coronavirus was detected in humans for the first time in the Since the discovery of this virus, COVID-19 has infected over 16 million people worldwide.
The symptoms of COVID-19 are similar to the flu and include sudden fever, cough, shortness of breath or difficulty breathing, and tiredness (fatigue).
The symptoms of COVID-19 have been found to be more severe in older age groups, as well as in individuals with hypertension, type 2 diabetes, asthma, and chronic obstructive pulmonary disease (COPD).
The incubation period of the virus is about 14-days, which means you may be infected before showing any symptoms. Once symptoms appear, an infected person may experience mild to severe symptoms such as:
Other less common symptoms are:
This study is evaluating whether the investigational COVID-19 vaccine is effective in preventing COVID-19.
A clinical trial, also referred to as a research study, is a scientific study that evaluates the safety and efficacy of an investigational medication. A research study may show that the investigational medication is better than, as good as, or worse than the standard treatment or inactive placebo. Qualified doctors, nurses and other medical professionals will conduct the study.
It is only through the completion of research studies that investigational medication can be evaluated, and if proven safe and effective, approved for general use by appropriate regulatory or health authorities, such as the U.S. Food and Drug Administration (FDA). Prescription medications in use today were first proven safe and effective in research studies.
When you sign up for a research study, your personal information is protected as required by law. The research team stores personal and private information with codes (instead of names or other identifying information), in order to not identify the participant or volunteer. The informed consent form that will be provided to you by the research team will have more information about privacy protection.
Participants who are eligible and take part in the study may receive compensation for time and travel. Please discuss this with the research site staff when they contact you.
This study is a Phase 3 study to evaluate whether the investigational COVID-19 vaccine, given in 2 doses, is safe and effective in preventing COVID-19.
The Phase 3 portion of this study is to enroll subjects who are generally representative of the study population groups in terms of racial and ethnic diversity and to include those at highest risk for severe COVID-19 disease, for example the elderly and those with significant comorbidities.